This item requires a subscription to Journal of Clinical Oncology.

Full Text Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent... van den Bent et al. J Clin Oncol.2009; 27: 1268-1274 To view this item, select one of the options below: Sign In User Name Sign in without cookies. Can't get past this page? Help with Cookies. Need to Activate? Password Remember my user name & password. Forgot your user name or password? Login via Athens or your institution Sign Up Subscribe to the Journal - Subscribe to the print and/or online journal. Order Online - Purchase your subscription online. [regain access to your recent online order] Renew Online - Renew your subscription online. [regain access to your recent online renewal] Purchase JCO Legacy Archive - [More Information] [regain access to your recent online Legacy Archive order]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by van den Bent, M. J. Articles by Gorlia, T. Search for Related Content PubMed PubMed Citation Articles by van den Bent, M. J. Articles by Gorlia, T. Social Bookmarking                            What's this?